14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $14.59 $16.67 Thursday, 25th Apr 2024 CPRX stock ended at $14.68. This is 2.91% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.91% from a day low at $14.59 to a day high of $15.01.
90 days $13.12 $17.50
52 weeks $11.09 $17.77

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
Nov 30, 2023 $14.17 $14.51 $14.06 $14.43 1 114 185
Nov 29, 2023 $14.29 $14.44 $14.03 $14.05 1 034 393
Nov 28, 2023 $14.04 $14.28 $13.94 $14.21 689 823
Nov 27, 2023 $13.97 $14.17 $13.77 $14.10 792 180
Nov 24, 2023 $13.89 $14.09 $13.82 $14.06 410 644
Nov 22, 2023 $13.87 $13.98 $13.69 $13.86 564 415
Nov 21, 2023 $13.63 $13.95 $13.61 $13.74 703 992
Nov 20, 2023 $13.81 $13.90 $13.53 $13.71 695 001
Nov 17, 2023 $13.52 $13.88 $13.45 $13.81 1 061 337
Nov 16, 2023 $13.66 $13.75 $13.26 $13.38 1 053 040
Nov 15, 2023 $13.34 $14.01 $13.23 $13.65 1 083 744
Nov 14, 2023 $12.93 $13.45 $12.91 $13.38 1 766 567
Nov 13, 2023 $12.81 $12.88 $12.43 $12.63 692 365
Nov 10, 2023 $12.41 $13.02 $12.41 $12.85 1 461 701
Nov 09, 2023 $13.39 $13.44 $12.27 $12.32 1 541 178
Nov 08, 2023 $12.80 $12.80 $12.37 $12.54 1 246 941
Nov 07, 2023 $13.00 $13.07 $12.83 $12.85 998 105
Nov 06, 2023 $13.11 $13.15 $12.86 $12.99 1 403 486
Nov 03, 2023 $12.70 $13.30 $12.69 $13.16 1 631 574
Nov 02, 2023 $12.65 $12.72 $12.37 $12.62 934 891
Nov 01, 2023 $12.36 $12.67 $12.11 $12.64 1 012 066
Oct 31, 2023 $12.14 $12.44 $11.90 $12.41 1 011 871
Oct 30, 2023 $12.11 $12.84 $12.09 $12.20 1 028 848
Oct 27, 2023 $13.41 $13.41 $11.99 $12.01 2 524 528
Oct 26, 2023 $12.98 $13.91 $11.99 $13.44 2 195 715
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT